Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up Study
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases
- Status
- TERMINATED
- Phase
- NA
Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Tomotherapy for Refractory Brain Metastases
- Status
- UNKNOWN
- Phase
- NA
Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M
- Status
- UNKNOWN
- Phase
- PHASE3
Pembrolizumab In Central Nervous System Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
nTMS for Motor Mapping of Rolandic Lesions
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles
- Status
- COMPLETED
- Phase
- PHASE1
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.
- Status
- COMPLETED
- Phase
- NA
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparing Immobilisation Shells in Cranial Radiotherapy
- Status
- COMPLETED
- Phase
- NA